← Back to directory

Raquel Duarte

Researcher Next ID · RN-040897

Researcher · Medicine

Universidade do Porto

Porto, Portugal

Accepting doctoral researchersFunding unknown
Works count
501
Citation count
10,385
H-index
43
i10-index
164

Research interests

Medicine
Tuberculosis Research and Epidemiology
Diagnosis and treatment of tuberculosis
Infectious Diseases and Tuberculosis
Pneumocystis jirovecii pneumonia detection and treatment
Mycobacterium research and diagnosis

Publications

  • Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

    American Journal of Respiratory and Critical Care Medicine · 2024 · 10.1164/rccm.202410-2096st

  • Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects

    Pulmonology · 2021 · 10.1016/j.pulmoe.2020.12.012

  • Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study

    European Respiratory Journal · 2021 · 10.1183/13993003.01786-2021

  • Clinical standards for the assessment, management and rehabilitation of post-TB lung disease

    The International Journal of Tuberculosis and Lung Disease · 2021 · 10.5588/ijtld.21.0425

  • MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network

    International Journal of Infectious Diseases · 2020 · 10.1016/j.ijid.2020.01.042

  • Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

    European Respiratory Journal · 2019 · 10.1183/13993003.01522-2019

  • Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

    American Journal of Respiratory and Critical Care Medicine · 2019 · 10.1164/rccm.201909-1874st

  • Risk factors for tuberculosis: diabetes, smoking, alcohol use, and the use of other drugs

    Jornal Brasileiro de Pneumologia · 2018 · 10.1590/s1806-37562017000000443

  • New drugs and perspectives for new anti-tuberculosis regimens ☆

    Pulmonology · 2018 · 10.1016/j.rppnen.2017.10.009

  • Point of care diagnostics for tuberculosis

    Pulmonology · 2018 · 10.1016/j.rppnen.2017.12.002

  • Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study

    European Respiratory Journal · 2017 · 10.1183/13993003.00387-2017

  • Tuberculosis, social determinants and co-morbidities (including HIV)

    Pulmonology · 2017 · 10.1016/j.rppnen.2017.11.003

  • Towards tuberculosis elimination: an action framework for low-incidence countries

    European Respiratory Journal · 2015 · https://doi.org/10.1183/09031936.00214014

  • Risk Assessment of Tuberculosis in Immunocompromised Patients. A TBNET Study

    American Journal of Respiratory and Critical Care Medicine · 2014 · 10.1164/rccm.201405-0967oc

  • Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement

    European Respiratory Journal · 2014 · 10.1183/09031936.00188313

  • The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement

    European Respiratory Journal · 2010 · 10.1183/09031936.00028510

  • LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis ? A TBNET consensus statement

    European Respiratory Journal · 2009 · 10.1183/09031936.00120908

Current projects

    No projects listed.